Entering text into the input field will update the search result below

IBio (IBIO +7.9%) says the NYSE Amex confirmed positive resolution of the biotech company's...

Jan. 27, 2012 9:55 AM ETiBio, Inc. (IBIO) StockIBIOBy: Carl Surran, SA News Editor

IBio (IBIO +7.9%) says the NYSE Amex confirmed positive resolution of the biotech company's listing deficiency. In November, the exchange indicated its review of iBio's Form 10-K for the fiscal year ended June 20, 2011 showed the company was not in compliance with Section 1003(1)(iv). (submitted by M.E. Garza)

Recommended For You

More Trending News

About IBIO Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
IBIO--
iBio, Inc.